Sana Biotechnology (SANA) Other Gross PP&E Adjustments (2020 - 2026)
Sana Biotechnology recorded quarterly Other Gross PP&E Adjustments of $44.5 million in Q1 2026, up 6.95% quarter-over-quarter from $41.6 million in Q4 2025, and down 40.51% year-over-year from $74.9 million in Q1 2025.
Sana Biotechnology's Other Gross PP&E Adjustments history runs 7 years deep, the most recent figure standing at $44.5 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments fell 40.51% year-over-year to $44.5 million; the TTM figure through Mar 2026 stood at $44.5 million (down 40.51% YoY), while the FY2025 annual figure was $41.6 million, down 42.58% from the prior year.
- Other Gross PP&E Adjustments came in at $44.5 million for Q1 2026 at Sana Biotechnology, up from $41.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $74.9 million in Q1 2025 to a low of -$8.0 million in Q1 2022.
- A 5-year average of $34.6 million and a median of $41.1 million in 2025 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments tumbled 181.06% in 2022 and soared 7223.56% in 2023, its largest moves.
- Sana Biotechnology's Other Gross PP&E Adjustments stood at $7.2 million in 2022, then surged by 397.75% to $36.1 million in 2023, then jumped by 100.96% to $72.5 million in 2024, then sank by 42.58% to $41.6 million in 2025, then rose by 6.95% to $44.5 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $44.5 million, $41.6 million, and $41.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - | 44.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.54 Mn |
| Mar 31, 2026 | 44.54 Mn |
| Dec 31, 2025 | 41.64 Mn |
| Dec 31, 2025 | 41.64 Mn |
| Sep 30, 2025 | 41.12 Mn |
| Sep 30, 2025 | 41.12 Mn |
| Jun 30, 2025 | 41.22 Mn |
| Jun 30, 2025 | 41.22 Mn |
| Mar 31, 2025 | 74.87 Mn |
| Mar 31, 2025 | 74.87 Mn |
| Dec 31, 2024 | 72.52 Mn |
| Dec 31, 2024 | 72.52 Mn |
| Sep 30, 2024 | 73.00 Mn |
| Sep 30, 2024 | 73.00 Mn |
| Jun 30, 2024 | 69.64 Mn |
| Jun 30, 2024 | 69.64 Mn |
| Mar 31, 2024 | 52.09 Mn |
| Mar 31, 2024 | 52.09 Mn |
| Dec 31, 2023 | 36.09 Mn |
| Dec 31, 2023 | 36.09 Mn |
| Sep 30, 2023 | 35.97 Mn |
| Sep 30, 2023 | 35.97 Mn |
| Jun 30, 2023 | 8.95 Mn |
| Jun 30, 2023 | 8.95 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Dec 31, 2022 | 7.25 Mn |
| Dec 31, 2022 | 7.25 Mn |
| Sep 30, 2022 | -505,000.00 |
| Sep 30, 2022 | -505,000.00 |
| Jun 30, 2022 | -6.46 Mn |
| Jun 30, 2022 | -6.46 Mn |
| Mar 31, 2022 | -8.01 Mn |
| Mar 31, 2022 | -8.01 Mn |
| Dec 31, 2021 | -14.05 Mn |
| Dec 31, 2021 | -14.05 Mn |
| Sep 30, 2021 | -8.12 Mn |
| Sep 30, 2021 | -8.12 Mn |
| Jun 30, 2021 | 8.06 Mn |
| Jun 30, 2021 | 8.06 Mn |
| Mar 31, 2021 | -2.85 Mn |
| Mar 31, 2021 | -2.85 Mn |
| Dec 31, 2020 | -10.37 Mn |
| Dec 31, 2020 | -10.37 Mn |